Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AD/PD 2022 | Developing therapeutics to rebuild the blood-brain barrier

Richard Daneman • 18 Mar 2022
AD/PD 2022
Alzheimer’s Disease Dementia

Richard Daneman, PhD, University of California San Diego, San Diego, CA, comments on the promise of the blood-brain barrier as a therapeutic target in neurological disease. Blood-brain barrier dysfunction and breakdown is an early symptom in numerous neurological diseases, thought to trigger subsequent neuronal dysfunction and ultimately, neurodegeneration. Many groups are looking to develop therapeutics to rebuild the blood-brain barrier, or prevent its breakdown, in order to tackle disease progression. This interview took place at the AD/PD™ 2022 Conference in Barcelona, Spain.

More from Richard Daneman

The blood-brain barrier in neurodegenerative disease: what are researchers looking at?
1:34
The blood-brain barrier in neurodegenerative disease: what are researchers looking at?
Richard Daneman • 18 Mar 2022
Role of the blood-brain barrier in Alzheimer’s disease
2:58
Role of the blood-brain barrier in Alzheimer’s disease
Richard Daneman • 18 Mar 2022
Blood-brain barrier dysfunction in disease
1:08
Blood-brain barrier dysfunction in disease
Richard Daneman • 18 Mar 2022

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals